Mednet Logo
HomePrimary Care
Primary Care

Primary Care

Physician perspectives on preventive care, chronic disease management, and evidence-based primary care practice.

Recent Discussions

Do you still prescribe a statin for patients with diabetes on GLP-1s for cardiovascular risk reduction if their LDL is at goal?

1 Answers

Mednet Member
Mednet Member
Cardiology · Hartford Hospital

I prescribe a statin or some other LDL-lowering medication to almost all patients with diabetes because most are not at their LDL-cholesterol goal, which is now 55 mg/dl. I also generally prescribe a low-dose statin even to patients with diabetes if they are below 55 mg/dl because patients with diab...

What is your approach to cancer patients who inquire about alternative or complementary treatments?

7
8 Answers

Mednet Member
Mednet Member
Radiation Oncology · Mayo Clinic

It depends a little bit on what specifically they want to use, and if they are truly investigating alternative medicine or complementary medicine. For people seeking full alternative medicine without any conventional treatment, I tell them that a research study showed that people who pursued the alt...

When do you prefer bariatric surgery such as sleeve gastrectomy or gastric bypass over an initial trial of a GLP-1 receptor agonist in patients with severe obesity and painful knee or hip osteoarthritis?

1
2 Answers

Mednet Member
Mednet Member
Rheumatology · Sorbonne Université

I believe that this type of decision should be made by obesity specialists and not by rheumatologists. However, we can anticipate that the patient's choice is paramount: some prefer radical options such as surgery, while others cannot bear to hear about it. The decision should only be made through d...

Do you need to hold Humira (adalimumab) during radiation for breast cancer in a patient with psoriatic arthritis?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

To my knowledge, there is not a lot of data on the interaction of adalimumab or other similar meds and radiation therapy. I am increasingly seeing this in my practice, however, for patients with psoriatic or rheumatoid arthritis. I discuss with patients that we have limited data on potential interac...

What is your approach to managing patients with recurrent ammonium urate kidney stones?

1 Answers

Mednet Member
Mednet Member
Nephrology · Mayo Clinic

Pure ammonium urate stones are very unusual, and, to my knowledge, there are no studies to guide us in their treatment. Much more common are magnesium ammonium urate stones, commonly known as "struvite". These are caused by urease-producing bacteria, usually Proteus or Klebsiella. I would first chec...

What is the preferred first-line non-insulin agent in patients with ketosis-prone diabetes during "remission" and evidence of preserved beta cell function?

2 Answers

Mednet Member
Mednet Member
Endocrinology · Texas Diabetes And Endocrinology Pa

Ketosis-prone diabetes (KPD) is an atypical form of diabetes that has been found in various racial and ethnic groups (Asian Indian, South American, West African, African American and others). People with KPD may present with DKA without the autoimmune findings of Type 1 diabetes. After the DKA episo...

Should we be more cautious with the use of GLP 1 R agonist therapy in patients with Type 1 diabetes mellitus and obesity given the increased risk of cardiovascular disease with high body weight variability?

1 Answers

Mednet Member
Mednet Member
Endocrinology · John H Stroger Jr Hospital of Cook County

There doesn't seem to be any evidence that GLP-1 RA would increase the risk of CV disease. Biologically, the benefits that have been shown in patients without Diabetes (the SELECT trial) should still be applicable for patients with Diabetes Type 1.The trials that didn't show much efficacy in glucose...

When managing patients with suspected MASLD, what specific criteria or findings would prompt you to refer them to hepatology?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Medical University of South Carolina College of Medicine

In patients with suspected MASLD, I consider referral to hepatology when there is evidence of fibrosis by elastography or if I don't see improvements in related parameters with weight loss and/or medical therapies (GLP1-related meds, SGLT2i, TZDs).

At what eGFR do you typically refer for vein mapping for a patient with advanced CKD who prefers hemodialysis when indicated?

2 Answers

Mednet Member
Mednet Member
Nephrology · Penn Medicine Cherry Hill

This is a big "it depends". Depends on trajectory of GFR loss, likelihood of preemptive transplant, my best clinical guess of the likelihood of successful fistula vs need for graft, etc. But in general, if it seems like HD start would be within 4-6 months.

How do you approach workup and management of hyperhidrosis?

1 Answers

Mednet Member
Mednet Member
Dermatology · MUSC Health

Oral anticholinergics